Clinical Trial Update: Efficacy and Safety Study of YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and Hyperlipidemia [Phase 3]

View source ↗

Summary

Phase 3 trial comparing YH16410 with rosuvastatin and telmisartan monotherapies in patients with hypertension and hyperlipidemia; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Hypertension

Drugs mentioned

• Rosuvastatin (rosuvastatin)
• Telmisartan (Telmisartan)
• YH16410 (YH16410)

Snippet

Sponsor: Yuhan Corporation | Conditions: Hyperlipidemia, Hypertension | Phase 3 | Status: COMPLETED